Table 1 Clinical and biochemical parameters of the study population according to the FG-IR and HOMA-IR indices (positive and negative)

Age (years)

29.94 ± 4.56

29.82 ± 4.55

31.1 ± 4.51

0.14

29.85 ± 4.56

30.77 ± 4.52

0.29

BMI (kg/m²)

26.62 ± 4.19

26.62 ± 4.16

26.63 ± 4.51

0.98

26.66 ± 4.22

26.22 ± 4.01

0.58

Insulin (μU/mL)

4.34 (2.8–7.4)

4 (2.67–6.41)

13.2 (11.9–14.83)

< 0.001

4 (2.67–6.41)

13.2 (12.15–14.83)

< 0.001

HomoCys (μU/mL)

11.57 (8.87–15.4)

11.9 (9.07–15.4)

9.92 (7.97–14.02)

0.077

11.7 (9.19–15.4)

9.83 (7.68–13.47)

0.04

Free-T (pg/mL)

3.25 ± 1.15

3.25 ± 1.13

3.21 ± 1.38

0.84

3.26 ± 1.15

3.14 ± 1.2

0.59

LH (IU/L)

6.48 (4.25–9.45)

6.48 (4.4–9.5)

6.05 (3.46–8.6)

0.21

6.48 (4.4–9.5)

6.46 (3.44–8.63)

0.34

FSH (IU/L)

6 (4.44–7.55)

6 (4.47–7.54)

6.15 (4–8.79)

0.91

6 (4.47–7.5)

6.6 (4.07–8.83)

0.75

TG (mg/dL)

116 (86–156)

116 (86–156)

117 (81–156.75)

0.71

114 (84–155)

125 (105–205.65)

0.07

FBG (mg/dL)

89.57 ± 9.48

89.58 ± 9.53

89.4 ± 9.15

0.92

88.69 ± 8.87

97.6 ± 11.16

< 0.001

TC (mg/dL)

172.46 ± 36.24

171.56 ± 36.7

180.72 ± 31.1

0.18

171.59 ± 36.26

180.46 ± 35.69

0.20

LDL-C (mg/dL)

98.54 ± 29.08

98.64 ± 29.54

97.63 ± 24.86

0.85

98.12 ± 29.01

102.38 ± 29.86

0.44

HDL-C (mg/dL)

44 (38–49.6)

44 (38–50)

43 (36.25–46.25)

0.18

44 (39–50)

41 (34–47)

0.048

TyG

4.62 (4.62 ± 0.24)

4.62 ± 0.24

4.63 ± 0.23

0.73

4.61 ± 0.23

4.74 ± 0.25

0.005

TG/HDL-C

2.68 (1.84–3.78)

2.68 (1.84–3.72)

2.73 (1.85–4.71)

0.75

2.66 (1.81–3.69)

3.32 (2.18–5)

0.033

TC/HDL-C

4 ± 1.13

3.95 ± 1.12

4.44 ± 1.15

0.024

3.94 ± 1.09

4.55 ± 1.36

0.005

FG-IR

20.76 (11.9–20.76)

21.79 (13.78–34.46)

7.07 (5.57–7.57)

< 0.001

21.79 (13.78–34.46)

7.48 (5.57–8.46)

< 0.001

HOMA-IR

0.98 (0.61–1.65)

0.89 (0.56–1.43)

3.1 (2.6–3.41)

< 0.001

0.89 (0.56–1.42)

3.14 (2.93–3.5)

< 0.001

QUICKI

0.39 ± 0.05

0.4 ± 0.04

0.32 ± 0.01

< 0.001

0.4 ± 0.04

0.32 ± 0.01

< 0.001